Choose date and time: ×
In the last half-hour
In the last 6 hours
Imugene appoints venture capital executive to board Proactive Investors (Australia)03:04
Earlier today
In the last 7 days
Better Buy: Novavax vs. Inovio Pharmaceuticals The Motley Fool17:03 18-May-19
Moleculin Biotech looks to treat worlds toughest cancers with therapies Proactive Investors (USA & Canada)21:18 17-May-19
Why Did ImmunoGen Plummet 32%? Investorideas.com20:07 17-May-19
Consortium granted £1.3M for gene therapy supply chain project European Pharmaceutical Manufacturer15:31 17-May-19
Market for single-use bioprocessing systems in Asia Pacific rises European Pharmaceutical Review12:28 17-May-19
3 Small-Cap Biotech Stocks You Can Buy Right Now The Motley Fool11:05 17-May-19
Takeda and Frazier team up to launch biopharmaceutical firm Pharmaceutical Technology10:19 17-May-19
Infinity Biotech – new partner of Astana Pro Team Astana Pro Team - Official Site08:38 17-May-19
Honglan Wang GlobeNewswire23:37 16-May-19
CEN Biotech Inc. announces a Merger Agreement with CSOC PR Newswire (Press Release)20:11 16-May-19
Nigeria looks to regulate emerging biotechnologies Cornell Alliance for Science16:10 16-May-19
Hedging success European Biotechnology News15:48 16-May-19
Hemostemix Closes First Tranche of Financing GlobeNewswire13:32 16-May-19
Celltrion to create 'bio-valley' in Incheon The Korea Times12:13 16-May-19
Symrise invests in biotech with latest acquisition CosmeticsDesign-Europe.com09:50 16-May-19
4SC AG: 4 upcoming conferences DGAP06:37 16-May-19

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Sorry, no headlines or news topics were found. Please try different keywords.